34 Einträge gefunden

1. Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.

   1. Fleischmann, A
   2. Huland, Hartwig
   3. Mirlacher, Martina
   4. Wilczak, Waldemar
   5. Simon, Ronald
   6. Erbersdobler, Andreas
   7. Sauter, G

   2012 - Forschungsinformationssystem des UKE
2. The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

   1. Tennstedt, Pierre
   2. Köster, Patricia
   3. Brüchmann, Andreas
   4. Mirlacher, Martina
   5. Haese, Alexander
   6. Steuber, Thomas
   7. Sauter, Guido

   2012 - Forschungsinformationssystem des UKE
3. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.

   1. Marx, Andreas
   2. Burandt, Eike Christian
   3. Choschzick, Matthias
   4. Simon, Ronald
   5. Yekebas, Emre F.
   6. Kaifi, Jussuf
   7. Mirlacher, Martina

   2010 - Forschungsinformationssystem des UKE
4. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.

   1. Marx, Andreas
   2. Zielinski, Margarete
   3. Kowitz, Charlotte-Marie
   4. Dancau, Ana Maria
   5. Thieltges, Sabrina
   6. Simon, Ronald
   7. Choschzick, Matthias

   2010 - Forschungsinformationssystem des UKE
5. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

   1. Minner, Sarah Jane Pauline
   2. Jessen, Birte
   3. Stiedenroth, Lars
   4. Burandt, Eike Christian
   5. Köllermann, Jens
   6. Mirlacher, Martina
   7. Erbersdobler, Andreas

   2010 - Forschungsinformationssystem des UKE
6. Tissue microarrays.

   1. Dancau, Ana Maria
   2. Simon, Ronald
   3. Mirlacher, Martina
   4. Sauter, Guido

   2010 - Forschungsinformationssystem des UKE
7. HER-2 amplification is highly homogenous in gastric cancer.

   1. Marx, Andreas
   2. Tharun, Lars
   3. Muth, Johanna
   4. Dancau, Ana Maria
   5. Simon, Ronald
   6. Yekebas, Emre F.
   7. Kaifi, Jussuf

   2009 - Forschungsinformationssystem des UKE
8. HER-2/neu analysis in breast cancer bone metastases.

   1. Zustin, Jozef
   2. Boddin, K
   3. Tsourlakis, Maria Christina
   4. Burandt, Eike Christian
   5. Mirlacher, Martina
   6. Jänicke, Fritz
   7. Izbicki, Jakob R.

   2009 - Forschungsinformationssystem des UKE
9. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

   1. Erbersdobler, Andreas
   2. Isbarn, Hendrik
   3. Dix, Kira
   4. Steiner, Isabel
   5. Schlomm, Thorsten
   6. Mirlacher, Martina
   7. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE
10. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.

    1. Erbersdobler, Andreas
    2. Isbarn, Hendrik
    3. Steiner, Isabel
    4. Schlomm, Thorsten
    5. Chun, Felix
    6. Mirlacher, Martina
    7. Sauter, Guido

    2009 - Forschungsinformationssystem des UKE
11. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.

    1. Fleischmann, Achim
    2. Schlomm, Thorsten
    3. Köllermann, Jens
    4. Sekulic, Nikolina
    5. Huland, Hartwig
    6. Mirlacher, Martina
    7. Sauter, Guido

    2009 - Forschungsinformationssystem des UKE
12. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

    1. Fleischmann, Achim
    2. Schlomm, Thorsten
    3. Huland, Hartwig
    4. Köllermann, Jens
    5. Simon, Philipp
    6. Mirlacher, Martina
    7. Salomon, Georg

    2008 - Forschungsinformationssystem des UKE
13. AMACR expression in colorectal cancer is associated with left-sided tumor localization.

    1. Marx, Andreas
    2. Simon, Philipp
    3. Simon, Ronald
    4. Mirlacher, Martina
    5. Izbicki, Jakob R.
    6. Yekebas, Emre F.
    7. Kaifi, Jussuf

    2008 - Forschungsinformationssystem des UKE
14. Clinical significance of p53 alterations in surgically treated prostate cancers.

    1. Schlomm, Thorsten
    2. Iwers, Liv
    3. Kirstein, Patrick
    4. Jessen, Birte
    5. Köllermann, Jens
    6. Minner, Sarah
    7. Passow-Drolet, Annika

    2008 - Forschungsinformationssystem des UKE
15. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.

    1. Al-Kuraya, Khawla
    2. Novotny, Hedvika
    3. Bavi, Prashant
    4. Siraj, Abdul K
    5. Uddin, Shahab
    6. Ezzat, Adnan
    7. Sanea, Nasser Al

    2007 - Forschungsinformationssystem des UKE
16. Molecular staging of prostate cancer in the year 2007.

    1. Schlomm, Thorsten
    2. Erbersdobler, Andreas
    3. Mirlacher, Martina
    4. Sauter, Guido

    2007 - Forschungsinformationssystem des UKE
17. Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.

    1. Woenckhaus, Matthias
    2. Bubendorf, Lukas
    3. Dalquen, Peter
    4. Foerster, Julia
    5. Blaszyk, Hagen
    6. Mirlacher, Martina
    7. Soler, Markus

    2007 - Forschungsinformationssystem des UKE
18. Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.

    1. Tapia, Coya
    2. Glatz, Katharina
    3. Novotny, Hedvika
    4. Lugli, Alessandro
    5. Horcic, Milo
    6. Seemayer, Christian A
    7. Tornillo, Luigi

    2007 - Forschungsinformationssystem des UKE
19. Tissue microarrays for comparing molecular features with proliferation activity in breast cancer.

    1. Ruiz, Christian
    2. Seibt, Silvia
    3. Khawla, Al Kuraya
    4. Siraj, Abdul K
    5. Mirlacher, Martina
    6. Schraml, Peter
    7. Maurer, Robert

    2006 - Forschungsinformationssystem des UKE
20. Epithelial growth factor receptor status in primary and recurrent ovarian cancer.

    1. Stadlmann, Sylvia
    2. Gueth, Uwe
    3. Reiser, Ulrich
    4. Diener, Pierre-Andre
    5. Zeimet, Alain Gustave
    6. Wight, Edward
    7. Mirlacher, Martina

    2006 - Forschungsinformationssystem des UKE